Volitionrx Limited Asset Turnover Ratio (VNRX), as of third quarter 2026, current and historic results, rankings and more - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Volitionrx Limited  (NYSE: VNRX)
 

Volitionrx Limited Asset Turnover Ratio

Quarterly Results, Trends, Rankings, Statistics

Volitionrx Limited asset turnover ratio, the ability of Volitionrx Limited's assets to generate revenue in the third quarter 2026, increased sequentially to 0.31 in the third quarter (Sep 30 2026), yet the ratio remained below the average, as VNRX's position remain challenging.

Within sector only one company achieved higher asset turnover ratio in the third quarter 2026. While ranking the asset turnover ratio, among all other companies, it is fair to say, that the company's position has deteriorated in the Third Quarter 2026 compared to the preceding quarter from 1281 to 1333.

Asset Turnover Ratio Definition


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

VNRX Asset Turnover Ratio (Sep 30 2026)
III. Quarter		 (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter
Y / Y Asset Change 112.32 % 67.45 % 6.06 % -21.57 % -49.14 %
Y / Y Revenue Change 157.28 % -1.97 % 299.81 % 133.25 % 32.19 %
Asset Turnover Ratio (TTM) 0.31 0.27 0.32 0.23 0.18
VNRX's Total Ranking # 1333 # 1281 # 0 # 2123 #
Seq. Asset Change -6.06 % 61.3 % 30.94 % 7.01 % -25.92 %
Seq. Revenue Change 304.83 % -59.53 % 120.36 % -28.73 % 54.24 %



Asset Turnover Ratio Company Ranking
Within: No.
In Vitro & In Vivo Diagnostic Substances Industry # 2
Healthcare Sector # 154
Overall Market # 1333

Asset Turnover Ratio Statistics
High Average Low
23.19 7.31 4.82
(Sep 30 2020)   (Dec 31 2020)




VNRX Company Profile • Back to VNRX Efficiency Comparisons • Compare VNRX Asset Turnover Ratio to its Competitors



Companies with similar Asset Turnover Ratio for the quarter ending Sep 30 2026, within Healthcare Sector Asset Turnover Ratio Revenues for 12 Months ending Sep 30 2026 Assets at quarter ending Sep 30 2026
3m Company  0.68 $ 25,247.000  Millions$ 36,904.750  Millions
Insmed Inc  0.68 $ 1,479.040  Millions$ 2,167.261  Millions
Illumina Inc   0.68 $ 4,538.000  Millions$ 6,666.250  Millions
Dentsply Sirona Inc   0.68 $ 3,575.000  Millions$ 5,263.000  Millions
Biomerica Inc   0.68 $ 4.338  Millions$ 6.413  Millions
Resmed Inc   0.67 $ 5,743.164  Millions$ 8,534.109  Millions
U S Physical Therapy Inc  0.67 $ 837.629  Millions$ 1,247.671  Millions
Eli Lilly And Company  0.67 $ 86,462.000  Millions$ 129,851.750  Millions
Bridgebio Pharma Inc   0.67 $ 945.540  Millions$ 1,421.523  Millions
Lantheus Holdings Inc   0.66 $ 1,561.890  Millions$ 2,361.195  Millions
Viskase Holdings inc   0.65 $ 271.837  Millions$ 420.742  Millions
Halozyme Therapeutics Inc   0.64 $ 1,802.448  Millions$ 2,812.199  Millions
Glaukos Corp  0.63 $ 578.355  Millions$ 921.716  Millions
Ceribell Inc   0.63 $ 109.203  Millions$ 174.150  Millions
Rhythm Pharmaceuticals Inc   0.62 $ 280.748  Millions$ 450.727  Millions
Sarepta Therapeutics Inc   0.61 $ 1,956.339  Millions$ 3,220.804  Millions
Heron Therapeutics Inc   0.61 $ 149.458  Millions$ 246.201  Millions
Intuitive Surgical Inc   0.60 $ 12,115.600  Millions$ 20,198.850  Millions
Supernus Pharmaceuticals inc   0.60 $ 865.106  Millions$ 1,444.793  Millions
Baxter International Inc   0.60 $ 11,784.000  Millions$ 19,776.500  Millions
Conmed Corporation  0.59 $ 1,369.288  Millions$ 2,311.365  Millions
Carlsmed Inc   0.59 $ 71.084  Millions$ 120.590  Millions
Bruker Corporation  0.58 $ 3,512.500  Millions$ 6,063.325  Millions
Iqvia Holdings Inc   0.58 $ 17,311.000  Millions$ 29,993.500  Millions
Merit Medical Systems Inc  0.58 $ 1,612.236  Millions$ 2,798.433  Millions
Gilead Sciences Inc   0.57 $ 30,988.000  Millions$ 54,017.750  Millions
Haemonetics Corporation  0.57 $ 1,382.737  Millions$ 2,415.705  Millions
Avantor Inc   0.57 $ 6,635.600  Millions$ 11,670.900  Millions
Bristol myers Squibb Company  0.57 $ 50,033.000  Millions$ 88,230.000  Millions
Rigel Pharmaceuticals Inc  0.56 $ 288.213  Millions$ 515.786  Millions



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.